Paclitaxel/carboplatin/etoposide (PCE) therapy for advanced poorly differentiated neuroendocrine (PDNE) carcinoma: A Minnie Pearl Cancer Research Network phase II trial.

被引：0
|
作者：
Miranda, FT
Spigel, DR
Hainsworth, JD
Thompson, DS
Yardley, DA
Burris, HA
Litchy, S
Shrader, M
Hon, JK
Corso, SW
Greco, FA
机构：
[1] Sarah Cannon Res Inst Tennessee, Nashville, TN USA
[2] Comprehens Canc Inst, Huntsville, AL USA
[3] Upstate Carolina CCOP, Spartanburg, SC USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2005年 / 23卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：322S / 322S
页数：1
相关论文
共 50 条
  • [31] Bevacizumab, eriotinib, and imatinib in the treatment of patients (pts) with advanced renal cell carcinoma (RCC): Update of a Minnie Pearl Cancer Research Network phase I/II trial
    Spigel, D.
    Hainsworth, J.
    Sosman, J.
    Patton, J.
    Thompson, D.
    Edwards, D.
    Sutton, V.
    Hart, L.
    Yost, K.
    Greco, F.
    EJC SUPPLEMENTS, 2005, 3 (02): : 227 - 227
  • [32] Single agent gefitinib in poor performance status patients with previously untreated advanced non-small cell lung cancer: A Minnie Pearl Cancer Research Network phase II trial.
    Dickson, NR
    Hainsworth, JD
    Spigel, DR
    Burris, HA
    Yardley, DA
    Thomas, M
    Jones, SF
    Scullin, DC
    Bradof, JE
    Greco, FA
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 637S - 637S
  • [33] Bevacizumab plus erlotinib in patients (pts) with carcinoma of unknown primary site: A phase II trial of the Minnie Pearl Cancer Research Network.
    Hainsworth, J. D.
    Spigel, D. R.
    Thompson, D. S.
    Shipley, D. L.
    Zubkus, J. D.
    Toomey, M. A.
    Burkett, E.
    Greco, F. A.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 129S - 129S
  • [34] Concurrent paclitaxel/carboplatin/infusional 5-FU/radiation therapy (RT) with or without subsequent esophageal resection in patients with localized esophageal cancer: A Minnie Pearl Cancer Research Network trial
    Gray, JR
    Hainsworth, JD
    Meluch, AA
    Spigel, DR
    Rosenoff, SH
    Bradof, JE
    Hermann, RC
    Meng, C
    Greco, FA
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 312S - 312S
  • [35] Gemcitabine and vinorelbine in the second-line treatment of nonsmall cell lung carcinoma patients - A minnie pearl cancer research network Phase II trial
    Hainsworth, JD
    Burris, HA
    Litchy, S
    Erland, JB
    Hon, JK
    Brierre, JE
    Greco, FA
    CANCER, 2000, 88 (06) : 1353 - 1358
  • [36] Combination chemotherapy with gemcitabine and irinotecan in patients with previously treated carcinoma of an unknown primary site - A Minnie Pearl Cancer Research Network Phase II Trial
    Hainsworth, JD
    Spigel, DR
    Raefsky, EL
    Kuzur, ME
    Yost, K
    Kommor, M
    Litchy, S
    Greco, FA
    CANCER, 2005, 104 (09) : 1992 - 1997
  • [37] Weekly paclitaxel/estramustine phosphate plus carboplatin administered either weekly or every 4 weeks in the treatment of hormone refractory prostate cancer (HRPC): A randomized phase II trial of the Minnie Pearl Cancer Research Network.
    Meluch, AA
    Greco, FA
    Burris, HA
    Erland, JB
    Khan, RA
    Rodriguez, GI
    Gandhi, JG
    Hainsworth, JD
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 421S - 421S
  • [38] Paclitaxel, carboplatin, and gemcitabine (PCG) versus gemcitabine and vinorelbine (GV) in chemotherapy naive patients (pts) with advanced non-small cell lung cancer (NSCLC): A phase III trial of the Minnie Pearl Cancer Research Network (MPCRN).
    Kuzur, ME
    Shipley, DL
    Spigel, DR
    Gray, JR
    Thompson, DS
    Hainsworth, JD
    Bradof, JE
    Webb, CD
    Gandhi, JG
    Beschorner, A
    Greco, FA
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 634S - 634S
  • [39] Phase II trial of combination nab-paclitaxel, carboplatin and gemcitabine in first line therapy of advanced urothelial carcinoma
    Ajjai Alva
    Stephanie Daignault
    David C. Smith
    Maha Hussain
    Investigational New Drugs, 2014, 32 : 188 - 194
  • [40] Adjuvant paclitaxel (P)/carboplatin (C) in stages I, II non-small cell lung cancer (NSCLC): Comparison of two schedules in phase II trials by the Minnie Pearl Cancer Research Network.
    McKay, CE
    Hainsworth, JD
    Spigel, DR
    Burris, HA
    Litchy, S
    Yardley, DA
    Houston, GA
    Bearden, JD
    Scullin, DC
    Greco, FA
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 651S - 651S
12345